Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
An MRI-defined measure of cerebral lesion severity to assess therapeutic effects in multiple sclerosis.
Using A Mixed Methods Approach to Develop A Discrete Choice Experiment In Multiple Sclerosis.
Teriflunomide in the treatment of multiple sclerosis: current evidence and future prospects.
Interaction between NADPH-oxidase and Rho-kinase in angiotensin II-induced microglial activation.
Inflammasome-Induced IL-1β Secretion in Microglia Is Characterized by Delayed Kinetics and Is Only Partially Dependent on Inflammatory Caspases.
Central nervous system de- and remyelination is independent from systemic cholesterol level in Theiler's murine encephalomyelitis.
Aging with multiple sclerosis: cognitive, emotional and neuropathological considerations.
MULTIPLE SCLEROSIS IN CHILDHOOD.
[Balance disorder and subacute hydrocephalus due to haemorrhage in a cerebral cavernous malformation].
Comparative clinical characteristics of early- and adult-onset multiple sclerosis patients with seizures.
Trichloropropane and dichlorohydrin associated with painful peripheral neurotoxicity.
MxA mRNA expression as a biomarker of interferon beta response in multiple sclerosis patients.
A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients.
Gut-associated lymphoid tissue, gut microbes and susceptibility to experimental autoimmune encephalomyelitis.
Multiple sclerosis: Fingolimod failure in progressive MS INFORMS future trials.
Albumin and Protein Oxidation are Predictors that Differentiate Relapsing-Remitting from Progressive Clinical Forms of Multiple Sclerosis.
Pharmacology and Structure of P2Y Receptors.
Distinct functionality of neutrophils in multiple sclerosis and neuromyelitis optica.
A case of demyelinating polyneuropathy associated with anti-myelin-associated glycoprotein antibodies with progressive quadriparesis and respiratory failure.
Age-dependent redistribution and hypersialylation of the central myelin paranodal loop membrane protein Opalin in the mouse brain.
Addressing the regulatory and scientific challenges in multiple sclerosis - a statement from the EU regulators.
The influence of vitamin D on postpartum relapse and quality of life in pregnant multiple sclerosis patients.
Markers of JC virus infection in patients with multiple sclerosis under natalizumab therapy.
The development of hematopoietic and mesenchymal stem cell transplantation as an effective treatment for multiple sclerosis.
Heterogeneity of root and nerve ultrasound pattern in CIDP patients.
Pages
« first
‹ previous
…
659
660
661
662
663
664
665
666
667
…
next ›
last »